Status:
UNKNOWN
Bilateral Serratus Intercostal Plane Block for Myocardial Revascularization (SERRINT)
Lead Sponsor:
Fundación Cardiovascular de Colombia
Conditions:
Pain, Postoperative
Pain Management
Eligibility:
All Genders
18-80 years
Phase:
NA
Brief Summary
Two-parallel arm, double-blind, individually randomized controlled trial. Primary endpoint: Fentanyl consumption in the first 48 postoperative hours. Secondary endpoints: Pain at rest, Pain on mov...
Detailed Description
Trial design: Two-parallel arm, double-blind, individually randomized controlled trial. Primary endpoint: Fentanyl consumption in the first 48 postoperative hours. Secondary endpoints: Pain at res...
Eligibility Criteria
Inclusion
- Patient between 18 years to 80 years
- Patient to myocardial revascularization by sternotomy
Exclusion
- Patient for combined surgery ( myocardial revascularization by sternotomy plus valve or maze)
- Emergency surgery
- Ejection Fraction less than 35%
- Allergy to the local anesthesics.
- Allergy to opioids
- Patient in who will be technically impossible the application of the blockade
Key Trial Info
Start Date :
January 15 2019
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 30 2019
Estimated Enrollment :
44 Patients enrolled
Trial Details
Trial ID
NCT03813225
Start Date
January 15 2019
End Date
September 30 2019
Last Update
August 22 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Luz Jenny Pacheco
Floridablanca, Santander Department, Colombia, 681004